{"meta":{"query_hash":"e8e26069d33e","filters":{"venue":"International Journal of Hematology-Oncology and Stem Cell Research"},"cohort_total":3,"direct_labels_cover":0,"predictions_cover":3,"exported":3,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/e8e26069d33e","api":"https://metacan.xera.ac/api/v1/cohort?venue=International+Journal+of+Hematology-Oncology+and+Stem+Cell+Research"},"results":[{"id":"W2896090606","doi":"10.18502/ijhoscr.v12i4.108","title":"Clinical Characteristics and Prognosis of Primary Tracheal Cancer: A Single Institution Experience","year":2018,"lang":"en","type":"article","venue":"International Journal of Hematology-Oncology and Stem Cell Research","topic":"Tracheal and airway disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Medicine; Radiation therapy; Proportional hazards model; Cancer registry; Hazard ratio; Cancer; Retrospective cohort study; Cohort; Disease; Internal medicine; Institutional review board; Survival analysis; Oncology; Surgery; Confidence interval","score_opus":0.1308047920082914,"score_gpt":0.45491432437420315,"score_spread":0.3241095323659118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896090606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992094,0.00017382449,0.00009268093,0.000035201472,0.000002946346,0.000013112874,0.00013507766,0.0000055560427,0.0003320748],"genre_scores_gemma":[0.99942493,0.000162285,0.0001552139,0.00002098003,0.000006887407,0.0000071194404,0.00014234726,0.0000027847552,0.0000774204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992995,0.00008716077,0.00006817151,0.0001419795,0.0001895431,0.00021361835],"domain_scores_gemma":[0.9982741,0.00023510604,0.00047178625,0.0001200882,0.00028077044,0.00061825634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000507312,0.00029050047,0.0003823925,0.00096089556,0.0013082089,0.0008474822,0.0005134754,0.0003726684,0.0010476275],"category_scores_gemma":[0.0024192596,0.00026217508,0.00028156445,0.0016008492,0.00061398576,0.00028607,0.0007087854,0.0003650321,0.00027961584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052194246,0.000030913867,0.9924321,0.000015917496,0.000012672805,0.0028784806,0.00062064186,0.00004631432,0.0003396968,0.000020096057,0.00022362368,0.0033272947],"study_design_scores_gemma":[0.000007630601,0.00024162269,0.97319895,0.000037444297,0.00003082917,0.0219559,0.0030532293,0.00025755854,0.0002819387,0.000052455845,0.0008564113,0.000025966683],"about_ca_topic_score_codex":0.08748669,"about_ca_topic_score_gemma":0.13105594,"teacher_disagreement_score":0.08748669,"about_ca_system_score_codex":0.0025102047,"about_ca_system_score_gemma":0.003259951,"threshold_uncertainty_score":0.1739549},"labels":[],"label_agreement":null},{"id":"W3154331373","doi":"10.18502/ijhoscr.v15i2.6039","title":"Association between the Interleukin-1 Receptor Antagonist (IL1RN) Variable Number of Tandem Repeats (VNTR) Polymorphism and Lymphoma","year":2021,"lang":"en","type":"article","venue":"International Journal of Hematology-Oncology and Stem Cell Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Lymphoma; Variable number tandem repeat; Interleukin 1 receptor antagonist; Immunology; Internal medicine; Allele; Polymerase chain reaction; Medicine; Gastroenterology; Biology; Oncology; Receptor antagonist; Receptor; Genetics; Antagonist; Gene","score_opus":0.02706038271301952,"score_gpt":0.32906333144070227,"score_spread":0.30200294872768274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154331373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99838734,0.00085796445,0.00024833047,0.000050782102,0.0000116298315,0.0000041804437,0.00009303844,0.0000054094007,0.00034129553],"genre_scores_gemma":[0.99924505,0.00020889027,0.00021944354,0.000020239071,0.000031053565,0.0000037637162,0.00010008461,0.0000018550809,0.00016966001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997359,0.00009622518,0.000020084324,0.000074567266,0.00004515083,0.000027950166],"domain_scores_gemma":[0.9988288,0.0005074783,0.00045515707,0.00004337429,0.00006613348,0.00009898806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003491394,0.0002601051,0.00021901043,0.0004988332,0.00015097873,0.00023183292,0.00021128157,0.0002649144,0.0029251447],"category_scores_gemma":[0.0012646158,0.00009468339,0.00021595065,0.00046513614,0.00019179872,0.000110976616,0.00009181318,0.0003319479,0.00016205522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043921705,0.0000520387,0.9913777,0.000029573519,0.00011441774,0.00028946044,0.00005745729,0.00008309489,0.0033886668,0.00004057287,0.00008480202,0.0040429938],"study_design_scores_gemma":[0.000015997472,0.00023239599,0.9961295,0.000015084824,0.00010652759,0.002282568,0.00004530121,0.00026773193,0.0005179883,0.00008495566,0.00029837276,0.0000035855744],"about_ca_topic_score_codex":0.00053833774,"about_ca_topic_score_gemma":0.0003880012,"teacher_disagreement_score":0.0029251447,"about_ca_system_score_codex":0.000080128346,"about_ca_system_score_gemma":0.00012655697,"threshold_uncertainty_score":0.009785652},"labels":[],"label_agreement":null},{"id":"W4407380418","doi":"10.18502/ijhoscr.v19i1.17819","title":"Pre-Treatment Peripheral Blood Parameters as Prognostic Biomarkers in Cancer Patients Receiving Immune Checkpoint Inhibitors","year":2025,"lang":"en","type":"article","venue":"International Journal of Hematology-Oncology and Stem Cell Research","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Algoma University; Essar Steel Algoma (Canada); Sault Area Hospital; University of Toronto","funders":"","keywords":"Medicine; Pembrolizumab; Nivolumab; Internal medicine; Oncology; Cancer; Ipilimumab; Lung cancer; Kidney cancer; Immune checkpoint; Immunotherapy","score_opus":0.02893273820637796,"score_gpt":0.3807658527763268,"score_spread":0.3518331145699488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407380418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970396,0.0017886991,0.00023139695,0.000085421794,0.000017152468,0.00001501366,0.00029767348,0.00000885534,0.00051616866],"genre_scores_gemma":[0.9992066,0.000244435,0.00020764368,0.000028406992,0.000026075104,0.000011344146,0.00021563025,0.000001704452,0.00005829431],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99968934,0.00010415356,0.000053851527,0.000039444825,0.00006373498,0.00004941996],"domain_scores_gemma":[0.997686,0.00081853307,0.00090036023,0.00005721725,0.00024174791,0.0002960884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006708781,0.000293438,0.00044254906,0.0009993884,0.0002565276,0.0006183809,0.00024905105,0.00041449015,0.001050624],"category_scores_gemma":[0.0035357082,0.0001361939,0.0002077432,0.0012963383,0.00021610266,0.0003801401,0.00023854375,0.00060942315,0.00022122457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027611587,0.000019959314,0.9972905,0.0000105,0.000012168301,0.000094660834,0.000010951048,0.000055013552,0.00019602287,0.0000062534505,0.000074247444,0.0019536193],"study_design_scores_gemma":[0.000016374268,0.00032766841,0.99694794,0.00002379658,0.00005110538,0.0009312629,0.00007611144,0.0007569443,0.00044558867,0.00004370704,0.0003745013,0.0000050903495],"about_ca_topic_score_codex":0.0006882003,"about_ca_topic_score_gemma":0.0007941251,"teacher_disagreement_score":0.001050624,"about_ca_system_score_codex":0.00022560835,"about_ca_system_score_gemma":0.00033046797,"threshold_uncertainty_score":0.0035479665},"labels":[],"label_agreement":null}]}